Prosecution Insights
Last updated: May 29, 2026
Application No. 18/314,211

NEURAL MODULATION OF AUTONOMIC NERVOUS SYSTEM TO ALTER MEMORY AND PLASTICITY OF THE AUTONOMIC NETWORK

Non-Final OA §102
Filed
May 09, 2023
Priority
Jun 26, 2017 — provisional 62/525,012 +2 more
Examiner
DIETRICH, JOSEPH M
Art Unit
3796
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
The Regents of the University of California
OA Round
3 (Non-Final)
81%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
748 granted / 925 resolved
+10.9% vs TC avg
Moderate +8% lift
Without
With
+8.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
27 currently pending
Career history
963
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
77.0%
+37.0% vs TC avg
§102
8.7%
-31.3% vs TC avg
§112
3.9%
-36.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 925 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 26 November 2025 has been entered. Terminal Disclaimer The terminal disclaimer filed on 03 February 2025 disclaiming the terminal portion of any patent granted on this application which would extend beyond the expiration date of U.S. Patent No. 11,642,530 has been reviewed and is accepted. The terminal disclaimer has been recorded. Response to Arguments The indicated allowability of claims 34 – 37 and 39 - 41 is withdrawn in view of further review. Rejections based on the newly cited reference(s) follow. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 34 – 37 and 39 - 41 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Naritoku et al. (US PGPUB 2002/0099418 – previously cited). Regarding claims 34 – 37 and 39 – 41, claim 34 recites a system for modulating the plasticity and/or memory of the autonomic cardiac nervous system comprising one or more components for delivering energy to a nerve or ganglion of the autonomic cardiac nervous system, wherein the delivering of energy to a nerve or ganglion of the autonomic cardiac nervous system comprises producing scalable block of efferent projecting axons to the heart. The producing scalable block of efferent projecting axons to the heart is functional language. There is not a processor configured to deliver the energy to a nerve or ganglion of the autonomic cardiac nervous system, wherein the delivering of energy to a nerve or ganglion of the autonomic cardiac nervous system comprises producing scalable block of efferent projecting axons to the heart. Therefore, any pulse generator would be capable of delivering such an energy. Naritoku teaches a system and method for altering the function or plasticity of a neural structure (e.g. paragraph 2) comprising, delivering energy to an autonomic neural structure (ganglion or nerve) (e.g. paragraphs 2); wherein the delivery of energy alters the function or plasticity of the neural structure during and beyond the delivery (e.g. paragraph 87). This reads on the claims as presently presented. The dependent claims recite sensing electrodes, stimulating electrodes, and specify the types of energy, but do not add any structures that would be used to deliver the specific type of energy that produces scalable block of efferent projecting axons to the heart. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JOSEPH M DIETRICH whose telephone number is (571)270-1895. The examiner can normally be reached Mon - Fri 8:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer McDonald can be reached on 571-270-3061. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JOSEPH M DIETRICH/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

May 09, 2023
Application Filed
Oct 01, 2024
Non-Final Rejection mailed — §102
Feb 03, 2025
Response Filed
May 28, 2025
Final Rejection mailed — §102
Nov 26, 2025
Request for Continued Examination
Dec 01, 2025
Response after Non-Final Action
Dec 17, 2025
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12636088
IMAGE-BASED SEEDING FOR REGISTRATION AND ASSOCIATED SYSTEMS AND METHODS
2y 10m to grant Granted May 26, 2026
Patent 12636495
STIMULATION ARTEFACT MODIFICATION METHOD
2y 11m to grant Granted May 26, 2026
Patent 12629529
WEARABLE CARDIOVERTER DEFIBRILLATOR CARE SYSTEM WITH HEALTH AND EMOTIONAL COMPANION ACCESSORY
5y 0m to grant Granted May 19, 2026
Patent 12616389
ESTIMATION SYSTEM, ESTIMATION METHOD, PROGRAM, ESTIMATION MODEL, BRAIN ACTIVITY TRAINING APPARATUS, BRAIN ACTIVITY TRAINING METHOD, AND BRAIN ACTIVITY TRAINING PROGRAM
3y 4m to grant Granted May 05, 2026
Patent 12613624
PLANNING AND/OR CONTROL SYSTEM FOR A NEUROMODULATION SYSTEM
5y 5m to grant Granted Apr 28, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
81%
Grant Probability
89%
With Interview (+8.3%)
3y 0m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 925 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month